New China COVID Vaccine Arriving But COVAX Pledge May Need A Booster
Executive Summary
China’s first domestically-developed recombinant protein vaccine for COVID-19 moves forward in late-stage trials in two countries.
You may also be interested in...
Let The Games Begin, Says COVID-19 Vaccine Quad Alliance
A COVID-19 vaccine alliance between US, Japan, India and Australia announced funding for Johnson & Johnson’s vaccine made by Biological E. Will the arrangement be extended to other vaccines and will the alliance push US to address materials export concerns, recently raised by Serum Institute?
US Is Holding On To Its Supply Of AstraZeneca COVID-19 Vaccine
US is keeping a ‘small inventory’ of AstraZeneca’s vaccine so people in the US can receive it immediately following authorization, White House official says. President Biden seeks to boost vaccine manufacturing in India in parntership with India, Japan, and Australia.
Coronavirus Update: At One-Year Mark, WHO Stresses Importance Of Fair Vaccine Distribution
Plus Pfizer/BioNTech report real-world data from Israel on its vaccine, while Roche’s Actemra misses Phase III endpoint in another combo study with Veklury.